PR4 IMPACT OF CLINICALLY MEANINGFUL REDUCTION IN DYSPAREUNIA ON HEALTH-RELATED QUALITY OF LIFE AMONG ENDOMETRIOSIS PATIENTS: A POOLED ANALYSIS OF TWO PHASE III CLINICAL TRIALS

Sanjay K. Agarwal, Ahmed M. Soliman, Robin Pokrzywinski, Karin S. Coyne
In: Value in Health · 2020 · vol. 23 , pp. S328 · doi:10.1016/j.jval.2020.04.1231 · W3028469325
article OA: closed CC0
🔓 Open OA copy View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-08-01 ⓘ

This analysis of two Phase III trials assessed the impact of clinically meaningful dyspareunia reduction on health-related quality of life in endometriosis patients.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosisdyspareunia

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-09-17T06:32:46.214484+00:00
License: CC0 · commercial use OK